The Future of Imaging Biomarkers in Alzheimer’s Disease Clinical Trials
Download this webinar featuring an exclusive panel of CNS experts addressing the state of biomarkers and the importance of imaging endpoints in Alzheimer’s Disease clinical trials following the Aducanumab approval.
- 3,000+ Research Trials Managed
- 1,500+ Peer-reviewed Publications
- ~25,000,000 (DICOM) Images Processed
- 800+ Molecules Labeled